Phathom Pharmaceuticals (PHAT) Operating Expenses: 2022-2025
Historic Operating Expenses for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $58.6 million.
- Phathom Pharmaceuticals' Operating Expenses fell 30.91% to $58.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.9 million, marking a year-over-year increase of 10.34%. This contributed to the annual value of $324.7 million for FY2024, which is 93.50% up from last year.
- Per Phathom Pharmaceuticals' latest filing, its Operating Expenses stood at $58.6 million for Q3 2025, which was down 37.93% from $94.4 million recorded in Q2 2025.
- Phathom Pharmaceuticals' Operating Expenses' 5-year high stood at $103.7 million during Q1 2025, with a 5-year trough of $30.1 million in Q1 2023.
- For the 3-year period, Phathom Pharmaceuticals' Operating Expenses averaged around $68.1 million, with its median value being $71.4 million (2024).
- As far as peak fluctuations go, Phathom Pharmaceuticals' Operating Expenses soared by 162.60% in 2024, and later crashed by 30.91% in 2025.
- Phathom Pharmaceuticals' Operating Expenses (Quarterly) stood at $46.6 million in 2022, then skyrocketed by 50.92% to $70.4 million in 2023, then climbed by 21.13% to $85.3 million in 2024, then tumbled by 30.91% to $58.6 million in 2025.
- Its last three reported values are $58.6 million in Q3 2025, $94.4 million for Q2 2025, and $103.7 million during Q1 2025.